Taconic Biosciences News

Taconic Biosciences News is your source for current and relevant news on how animal models are being used to drive drug discovery. Use the links below to explore exciting announcements from Taconic via Press Releases, Taconic’s press coverage in Publications and Media, and critical scientific insights within Industry News.

Who Owns CRISPR?

The Scientist details CRISPR/Cas system technology being utilized at Taconic Biosciences: "On April 15, 2014, the US Patent and Trademark Office (USPTO) awarded the first patent for use the CRISPR/Cas system to edit eukaryotic genomes to Feng Zhang of the Broad Institute and MIT. Originally a bacterial or archaeal defense system that uses viral DNA inserted into the genome (CRISPR) as a guide to cut the genomic...

Read More

Better Tools for Improved Immuno-Oncology Research

Genetic Engineering & Biotechnology News features Taconic Biosciences because of their knowledge of Immuno-Oncology research: "Predictive Models Can Reduce Late-Stage Failures and Accelerate Time-to-Market for Effective Drug Candidates - Our ability to understand the complexity of human cancer progression was once limited by research models that did not recapitulate the disease with full accuracy. Those limitations are now behind us. Thanks to advances in immune-deficient and genetically...

Read More

Taconic Biosciences and Cellaria Biosciences Agree to Scientific Collaboration to Facilitate Xenograft Use in Oncology Research

Novel Technology Will Improve Process of Generating Cells from Patient-Derived Tumors HUDSON, NY – March 25, 2015 - Taconic Biosciences and Cellaria Biosciences announced that the two companies have entered into a scientific collaboration designed to facilitate and improve the utility of patient-derived xenografts (PDXs) in animal models for oncology and immuno-oncology research. Cellaria’s novel methodologies for generating cells from patient tumors will complement Taconic’s industry-leading portfolio...

Read More

Taconic Biosciences Strengthens Japanese Distribution and Breeding Partnerships

Hudson, New York - March 17, 2015 - Taconic Biosciences, a leading provider of genetically modified solutions to researchers worldwide, announced today a new agreement and the expansion of an existing agreement that together will improve access to lab animal models for researchers in Japan. These moves build on the collaborative efforts that Taconic has already had in place with Micell Trading Corporation and CLEA Japan, Inc.,...

Read More

Taconic Biosciences Support Helps to Advance Rare Disease Research

Rare Genomics Institute Launches 2015 Be HEARD Challenge With Taconic as a Sponsor HUDSON, NY - March 3, 2015 - Taconic Biosciences today announced its partnership with the Rare Genomics Institute (RGI) to support the 2015 Rare Disease Science Challenge: Be HEARD (Helping Empower and Accelerate Research Discoveries). The Challenge, part of a wide-ranging portfolio of activity timed to coincide with Rare Disease Day, provides personalized rare...

Read More

How Lab Animal Health Standards Are Evolving

Taconic's Dr. Jeffrey Lohmiller authors this composition in Genetic Engineering & Biotechnology News, and he talks about animal health standards and their advancement over time: "Six Pillars That Can Help You Choose the Right Approach - Stringent husbandry practices and regular health testing at both the lab and breeder site are essential to maintaining animals at a more restrictive health standard. Health standards have always played a...

Read More

Winter Storm Juno

Hudson, New York — January 26, 2015 - Given the wide spread impact of Winter Storm Juno, Taconic Biosciences is anticipating delayed deliveries for some of our customers during the height of the storm. Storms of this magnitude often cause pick-up and delivery delays. Taconic may have limited hours of operation on Tuesday, January 27th. If you have any questions regarding your delivery, please contact our Customer...

Read More

Taconic Biosciences Launches New Health Standard

Excluded Flora Standard Allows for Models Free of Two Additional Commensal Organisms Hudson, New York — October 20, 2014 - Taconic Biosciences today announced that it has added the Excluded Flora (EF) standard to the set of precisely defined health standards applied to its production of laboratory mice and rats. The EF standard makes available animals that are free of Proteus spp. and Segmented Filamentous Bacteria (SFB)...

Read More

Taconic Biosciences Changes to a New Set of Genotyping Codes

Hudson, New York — October 20, 2014 - As part of Taconic’s commitment to better serve its clients, we have decided to change the way we document our genotyping codes. Historically, Taconic has used a one-letter genotyping code to document mutated alleles. However, due to the increase in complexity of mutant allele types and the challenges of documenting them, Taconic has decided to replace its old genotyping...

Read More

Taconic Changes Legal Name to Taconic Biosciences

Hudson, NY — September 23, 2014 - Taconic announced today that it has changed the legal name of the company from Taconic Farms, Inc. to Taconic Biosciences, Inc. The change in Taconic’s name reflects the evolution of the firm from primarily a breeder of laboratory mice and rats to a science and technologies-based service company focused on providing genetically engineered models and services to biomedical and biopharmaceutical...

Read More